143 related articles for article (PubMed ID: 24986638)
1. A molecular pathway analysis of the glutamatergic-monoaminergic interplay serves to investigate the number of depressive records during citalopram treatment.
Drago A; Cocchi E; Crisafulli C; Serretti A
J Neural Transm (Vienna); 2015 Mar; 122(3):465-75. PubMed ID: 24986638
[TBL] [Abstract][Full Text] [Related]
2. A genomewide association study of citalopram response in major depressive disorder.
Garriock HA; Kraft JB; Shyn SI; Peters EJ; Yokoyama JS; Jenkins GD; Reinalda MS; Slager SL; McGrath PJ; Hamilton SP
Biol Psychiatry; 2010 Jan; 67(2):133-8. PubMed ID: 19846067
[TBL] [Abstract][Full Text] [Related]
3. Association between treatment-emergent suicidal ideation with citalopram and polymorphisms near cyclic adenosine monophosphate response element binding protein in the STAR*D study.
Perlis RH; Purcell S; Fava M; Fagerness J; Rush AJ; Trivedi MH; Smoller JW
Arch Gen Psychiatry; 2007 Jun; 64(6):689-97. PubMed ID: 17548750
[TBL] [Abstract][Full Text] [Related]
4. Association of polymorphisms in genes regulating the corticotropin-releasing factor system with antidepressant treatment response.
Binder EB; Owens MJ; Liu W; Deveau TC; Rush AJ; Trivedi MH; Fava M; Bradley B; Ressler KJ; Nemeroff CB
Arch Gen Psychiatry; 2010 Apr; 67(4):369-79. PubMed ID: 20368512
[TBL] [Abstract][Full Text] [Related]
5. SLC6A4 polymorphisms and age of onset in late-life depression on treatment outcomes with citalopram: a Sequenced Treatment Alternatives to Relieve Depression (STAR*D) report.
Shiroma PR; Drews MS; Geske JR; Mrazek DA
Am J Geriatr Psychiatry; 2014 Nov; 22(11):1140-8. PubMed ID: 23973251
[TBL] [Abstract][Full Text] [Related]
6. Association of mu-opioid receptor variants and response to citalopram treatment in major depressive disorder.
Garriock HA; Tanowitz M; Kraft JB; Dang VC; Peters EJ; Jenkins GD; Reinalda MS; McGrath PJ; von Zastrow M; Slager SL; Hamilton SP
Am J Psychiatry; 2010 May; 167(5):565-73. PubMed ID: 20194481
[TBL] [Abstract][Full Text] [Related]
7. Common genetic variation in the indoleamine-2,3-dioxygenase genes and antidepressant treatment outcome in major depressive disorder.
Cutler JA; Rush AJ; McMahon FJ; Laje G
J Psychopharmacol; 2012 Mar; 26(3):360-7. PubMed ID: 22282879
[TBL] [Abstract][Full Text] [Related]
8. An evaluation of the quick inventory of depressive symptomatology and the hamilton rating scale for depression: a sequenced treatment alternatives to relieve depression trial report.
Rush AJ; Bernstein IH; Trivedi MH; Carmody TJ; Wisniewski S; Mundt JC; Shores-Wilson K; Biggs MM; Woo A; Nierenberg AA; Fava M
Biol Psychiatry; 2006 Mar; 59(6):493-501. PubMed ID: 16199008
[TBL] [Abstract][Full Text] [Related]
9. Residual symptoms after remission of major depressive disorder with citalopram and risk of relapse: a STAR*D report.
Nierenberg AA; Husain MM; Trivedi MH; Fava M; Warden D; Wisniewski SR; Miyahara S; Rush AJ
Psychol Med; 2010 Jan; 40(1):41-50. PubMed ID: 19460188
[TBL] [Abstract][Full Text] [Related]
10. The impact of catechol-O-methyltransferase SNPs and haplotypes on treatment response phenotypes in major depressive disorder: a case-control association study.
Kocabas NA; Faghel C; Barreto M; Kasper S; Linotte S; Mendlewicz J; Noro M; Oswald P; Souery D; Zohar J; Massat I
Int Clin Psychopharmacol; 2010 Jul; 25(4):218-27. PubMed ID: 20531207
[TBL] [Abstract][Full Text] [Related]
11. Riluzole combination therapy for moderate-to-severe major depressive disorder: A randomized, double-blind, placebo-controlled trial.
Salardini E; Zeinoddini A; Mohammadinejad P; Khodaie-Ardakani MR; Zahraei N; Zeinoddini A; Akhondzadeh S
J Psychiatr Res; 2016 Apr; 75():24-30. PubMed ID: 26800392
[TBL] [Abstract][Full Text] [Related]
12. Common genetic variation and antidepressant efficacy in major depressive disorder: a meta-analysis of three genome-wide pharmacogenetic studies.
; ;
Am J Psychiatry; 2013 Feb; 170(2):207-17. PubMed ID: 23377640
[TBL] [Abstract][Full Text] [Related]
13. Is prior course of illness relevant to acute or longer-term outcomes in depressed out-patients? A STAR*D report.
Rush AJ; Wisniewski SR; Zisook S; Fava M; Sung SC; Haley CL; Chan HN; Gilmer WS; Warden D; Nierenberg AA; Balasubramani GK; Gaynes BN; Trivedi MH; Hollon SD
Psychol Med; 2012 Jun; 42(6):1131-49. PubMed ID: 22008447
[TBL] [Abstract][Full Text] [Related]
14. Clinical features and drug induced side effects in early versus late antidepressant responders.
Fabbri C; Marsano A; Balestri M; De Ronchi D; Serretti A
J Psychiatr Res; 2013 Oct; 47(10):1309-18. PubMed ID: 23800418
[TBL] [Abstract][Full Text] [Related]
15. Neuroplasticity and second messenger pathways in antidepressant efficacy: pharmacogenetic results from a prospective trial investigating treatment resistance.
Fabbri C; Crisafulli C; Calati R; Albani D; Forloni G; Calabrò M; Martines R; Kasper S; Zohar J; Juven-Wetzler A; Souery D; Montgomery S; Mendlewicz J; Serretti A
Eur Arch Psychiatry Clin Neurosci; 2017 Dec; 267(8):723-735. PubMed ID: 28260126
[TBL] [Abstract][Full Text] [Related]
16. DISC1-TSNAX and DAOA genes in major depression and citalopram efficacy.
Arias B; Fabbri C; Serretti A; Drago A; Mitjans M; Gastó C; Catalán R; Fañanás L
J Affect Disord; 2014 Oct; 168():91-7. PubMed ID: 25043320
[TBL] [Abstract][Full Text] [Related]
17. Trajectories of individual symptoms in remitters versus non-remitters with depression.
Sakurai H; Uchida H; Abe T; Nakajima S; Suzuki T; Pollock BG; Sato Y; Mimura M
J Affect Disord; 2013 Nov; 151(2):506-513. PubMed ID: 23886402
[TBL] [Abstract][Full Text] [Related]
18. Quality of Life and Functioning in Comorbid Posttraumatic Stress Disorder and Major Depressive Disorder After Treatment With Citalopram Monotherapy.
Steiner AJ; Boulos N; Mirocha J; Wright SM; Collison KL; IsHak WW
Clin Neuropharmacol; 2017; 40(1):16-23. PubMed ID: 27764051
[TBL] [Abstract][Full Text] [Related]
19. Sequence variations of ABCB1, SLC6A2, SLC6A3, SLC6A4, CREB1, CRHR1 and NTRK2: association with major depression and antidepressant response in Mexican-Americans.
Dong C; Wong ML; Licinio J
Mol Psychiatry; 2009 Dec; 14(12):1105-18. PubMed ID: 19844206
[TBL] [Abstract][Full Text] [Related]
20. A randomized trial of citalopram versus placebo in outpatients with asthma and major depressive disorder: a proof of concept study.
Brown ES; Vigil L; Khan DA; Liggin JD; Carmody TJ; Rush AJ
Biol Psychiatry; 2005 Dec; 58(11):865-70. PubMed ID: 15993860
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
